Profile | GDS4284 / 216985_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 36.893 | 21 |
GSM687648 | Patient 402 control | 209.262 | 50 |
GSM687653 | Patient 403 control | 105.803 | 37 |
GSM687658 | Patient 404 control | 157.225 | 43 |
GSM687663 | Patient 411 control | 171.982 | 44 |
GSM687668 | Patient 422 control | 96.0762 | 34 |
GSM687673 | Patient 424 control | 188.365 | 46 |
GSM687678 | Patient 425 control | 260.587 | 52 |
GSM687683 | Patient 427 control | 88.7984 | 30 |
GSM687688 | Patient 428 control | 101.823 | 35 |
GSM687695 | Patient 441 control | 629.766 | 66 |
GSM687699 | Patient 443 control | 318.175 | 54 |
GSM687704 | Patient 444 control | 98.2335 | 34 |
GSM687707 | Patient 448 control | 150.249 | 38 |
GSM687712 | Patient 449 control | 74.8605 | 29 |
GSM687719 | Patient 450 control | 204.844 | 45 |
GSM687724 | Patient 451 control | 104.042 | 32 |
GSM687728 | Patient 452 control | 568.233 | 66 |
GSM687646 | Patient 401 treated 24h | 4.51943 | 1 |
GSM687649 | Patient 402 treated 24h | 243.257 | 53 |
GSM687665 | Patient 411 treated 24h | 152.87 | 41 |
GSM687651 | Patient 402 treated 4 weeks | 175.32 | 44 |
GSM687667 | Patient 411 treated 4 weeks | 154.902 | 43 |
GSM687670 | Patient 422 treated 24h | 191.581 | 46 |
GSM687671 | Patient 422 treated 4 weeks | 164.839 | 45 |
GSM687654 | Patient 403 treated 24h | 75.8746 | 32 |
GSM687675 | Patient 424 treated 24h | 148.99 | 40 |
GSM687685 | Patient 427 treated 24h | 138.139 | 41 |
GSM687656 | Patient 403 treated 4 weeks | 124.665 | 41 |
GSM687677 | Patient 424 treated 4 weeks | 62.9605 | 26 |
GSM687687 | Patient 427 treated 4 weeks | 131.389 | 42 |
GSM687692 | Patient 428 treated 4h | 92.2809 | 32 |
GSM687716 | Patient 449 treated 4h | 155.96 | 44 |
GSM687722 | Patient 450 treated 4h | 91.786 | 30 |
GSM687680 | Patient 425 treated 24h | 114.263 | 37 |
GSM687690 | Patient 428 treated 24h | 88.3963 | 32 |
GSM687700 | Patient 443 treated 24h | 372.295 | 55 |
GSM687705 | Patient 444 treated 24h | 101.322 | 36 |
GSM687714 | Patient 449 treated 24h | 104.471 | 37 |
GSM687721 | Patient 450 treated 24h | 242.615 | 48 |
GSM687682 | Patient 425 treated 4 weeks | 19.0179 | 12 |
GSM687694 | Patient 428 treated 4 weeks | 92.7333 | 35 |
GSM687702 | Patient 443 treated 4 weeks | 90.3061 | 31 |
GSM687718 | Patient 449 treated 4 weeks | 70.2138 | 27 |
GSM687723 | Patient 450 treated 4 weeks | 98.2233 | 33 |
GSM687661 | Patient 404 treated 4h | 196.073 | 47 |
GSM687710 | Patient 448 treated 4h | 100.995 | 34 |
GSM687726 | Patient 451 treated 4h | 199.156 | 45 |
GSM687730 | Patient 452 treated 4h | 264.665 | 38 |
GSM687660 | Patient 404 treated 24h | 712.59 | 70 |
GSM687697 | Patient 441 treated 24h | 654.746 | 67 |
GSM687709 | Patient 448 treated 24h | 178.192 | 44 |
GSM687725 | Patient 451 treated 24h | 74.7896 | 25 |
GSM687729 | Patient 452 treated 24h | 1172 | 78 |
GSM687727 | Patient 451 treated 4 weeks | 78.42 | 26 |
GSM687731 | Patient 452 treated 4 weeks | 374.113 | 58 |